These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 28719060)
1. Drug use and phylogenetic clustering of hepatitis C virus infection among people who use drugs in Vancouver, Canada: A latent class analysis approach. Jacka B; Bray BC; Applegate TL; Marshall BDL; Lima VD; Hayashi K; DeBeck K; Raghwani J; Harrigan PR; Krajden M; Montaner JSG; Grebely J J Viral Hepat; 2018 Jan; 25(1):28-36. PubMed ID: 28719060 [TBL] [Abstract][Full Text] [Related]
2. A latent class approach to identify multi-risk profiles associated with phylogenetic clustering of recent hepatitis C virus infection in Australia and New Zealand from 2004 to 2015. Bartlett SR; Applegate TL; Jacka BP; Martinello M; Lamoury FM; Danta M; Bradshaw D; Shaw D; Lloyd AR; Hellard M; Dore GJ; Matthews GV; Grebely J J Int AIDS Soc; 2019 Feb; 22(2):e25222. PubMed ID: 30746864 [TBL] [Abstract][Full Text] [Related]
3. Phylogenetic clustering of hepatitis C virus among people who inject drugs in Vancouver, Canada. Jacka B; Applegate T; Krajden M; Olmstead A; Harrigan PR; Marshall B; DeBeck K; Milloy MJ; Lamoury F; Pybus OG; Lima VD; Magiorkinis G; Montoya V; Montaner J; Joy J; Woods C; Dobrer S; Dore GJ; Poon AF; Grebely J Hepatology; 2014 Nov; 60(5):1571-1580. PubMed ID: 25042607 [TBL] [Abstract][Full Text] [Related]
4. Methamphetamine injecting is associated with phylogenetic clustering of hepatitis C virus infection among street-involved youth in Vancouver, Canada. Cunningham EB; Jacka B; DeBeck K; Applegate TL; Harrigan PR; Krajden M; Marshall BD; Montaner J; Lima VD; Olmstead AD; Milloy MJ; Wood E; Grebely J Drug Alcohol Depend; 2015 Jul; 152():272-6. PubMed ID: 25977204 [TBL] [Abstract][Full Text] [Related]
5. HIV infection and hepatitis C virus genotype 1a are associated with phylogenetic clustering among people with recently acquired hepatitis C virus infection. Bartlett SR; Jacka B; Bull RA; Luciani F; Matthews GV; Lamoury FM; Hellard ME; Hajarizadeh B; Teutsch S; White B; Maher L; Dore GJ; Lloyd AR; Grebely J; Applegate TL Infect Genet Evol; 2016 Jan; 37():252-8. PubMed ID: 26631810 [TBL] [Abstract][Full Text] [Related]
6. Never injected, but hepatitis C virus-infected: a study among self-declared never-injecting drug users from the Amsterdam Cohort Studies. van den Berg CH; van de Laar TJ; Kok A; Zuure FR; Coutinho RA; Prins M J Viral Hepat; 2009 Aug; 16(8):568-77. PubMed ID: 19243497 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus phylogenetic clustering is associated with the social-injecting network in a cohort of people who inject drugs. Sacks-Davis R; Daraganova G; Aitken C; Higgs P; Tracy L; Bowden S; Jenkinson R; Rolls D; Pattison P; Robins G; Grebely J; Barry A; Hellard M PLoS One; 2012; 7(10):e47335. PubMed ID: 23110068 [TBL] [Abstract][Full Text] [Related]
8. Epidemiological aspects of HCV infection in non-injecting drug users in the Brazilian state of Pará, eastern Amazon. Oliveira-Filho AB; Sawada L; Pinto LC; Locks D; Bahia SL; Castro JA; Hermes RB; Brasil-Costa I; Amaral CE; Lemos JA Virol J; 2014 Feb; 11():38. PubMed ID: 24564954 [TBL] [Abstract][Full Text] [Related]
9. Association between non-injection drug use and hepatitis C infection among HIV-negative men who have sex with men. Zhao J; Green C; Markham C; Fujimoto K; Nyitray AG; Hwang LY BMC Infect Dis; 2024 Sep; 24(1):985. PubMed ID: 39285350 [TBL] [Abstract][Full Text] [Related]
10. High prevalence of Hepatitis C Virus infection among people who use crack cocaine in an important international drug trafficking route in Central-West Region Brazil. Castro VOL; Kamili S; Forbi JC; Stabile AC; da Silva EF; do Valle Leone de Oliveira SM; de Carvalho PRT; Puga MAM; Tanaka TSO; do Lago BV; Ibanhes ML; Araujo A; Tejada-Strop A; Lin Y; Xia GL; Sue A; Teles SA; Motta-Castro ARC Infect Genet Evol; 2020 Nov; 85():104488. PubMed ID: 32745809 [TBL] [Abstract][Full Text] [Related]
11. Phylogenetic analysis of full-length, early infection, hepatitis C virus genomes among people with intravenous drug use: the InC Rodrigo C; Eltahla AA; Bull RA; Luciani F; Grebely J; Dore GJ; Applegate T; Page K; Bruneau J; Morris MD; Cox AL; Osburn W; Kim AY; Shoukry NH; Lauer GM; Maher L; Schinkel J; Prins M; Hellard M; Lloyd AR; J Viral Hepat; 2017 Jan; 24(1):43-52. PubMed ID: 27808453 [TBL] [Abstract][Full Text] [Related]
12. Phylogenetic and phylodynamic analyses of hepatitis C virus subtype 1a in Okinawa, Japan. Hoshino K; Sugiyama M; Date T; Maruwaka S; Arakaki S; Shibata D; Maeshiro T; Hokama A; Sakugawa H; Kanto T; Fujita J; Mizokami M J Viral Hepat; 2018 Aug; 25(8):976-985. PubMed ID: 29577516 [TBL] [Abstract][Full Text] [Related]
13. Correlates of hepatitis C viral clustering among people who inject drugs in Baltimore. Hackman J; Falade-Nwulia O; Patel EU; Mehta SH; Kirk GD; Astemborski J; Ray SC; Thomas DL; Laeyendecker O Infect Genet Evol; 2020 Jan; 77():104078. PubMed ID: 31669367 [TBL] [Abstract][Full Text] [Related]
14. Transmission of hepatitis C virus infection among younger and older people who inject drugs in Vancouver, Canada. Jacka B; Applegate T; Poon AF; Raghwani J; Harrigan PR; DeBeck K; Milloy MJ; Krajden M; Olmstead A; Joy JB; Marshall BD; Hayashi K; Pybus OG; Lima VD; Magiorkinis G; Montaner J; Lamoury F; Dore GJ; Wood E; Grebely J J Hepatol; 2016 Jun; 64(6):1247-55. PubMed ID: 26924451 [TBL] [Abstract][Full Text] [Related]
15. Emergence of hepatitis C virus genotype 4: phylogenetic analysis reveals three distinct epidemiological profiles. de Bruijne J; Schinkel J; Prins M; Koekkoek SM; Aronson SJ; van Ballegooijen MW; Reesink HW; Molenkamp R; van de Laar TJ J Clin Microbiol; 2009 Dec; 47(12):3832-8. PubMed ID: 19794040 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000-2017: Protective effects of non-injecting drug use. Des Jarlais DC; Arasteh K; Feelemyer J; McKnight C; Barnes DM; Perlman DC; Uuskula A; Cooper HLF; Tross S Drug Alcohol Depend; 2018 Nov; 192():74-79. PubMed ID: 30243142 [TBL] [Abstract][Full Text] [Related]
17. Short and sporadic injecting cessation episodes as predictors of incident hepatitis C virus infection: findings from a cohort study of people who inject drugs in Montréal, Canada. Fortier E; Artenie AA; Zang G; Jutras-Aswad D; Roy É; Grebely J; Bruneau J Addiction; 2019 Aug; 114(8):1495-1503. PubMed ID: 30957310 [TBL] [Abstract][Full Text] [Related]
18. Molecular and epidemiological aspects of hepatitis C virus infection among crack cocaine users. Del-Rios NHA; de Araujo LA; Martins RMB; Guimarães RA; de Matos MAD; Caetano KAA; Pinheiro RS; da Silva França DD; da Silva LN; Teles SA; Dos Santos Carneiro MA J Med Virol; 2020 Aug; 92(8):1239-1245. PubMed ID: 31746475 [TBL] [Abstract][Full Text] [Related]
19. Characterization of Hepatitis C Virus (HCV) Envelope Diversification from Acute to Chronic Infection within a Sexually Transmitted HCV Cluster by Using Single-Molecule, Real-Time Sequencing. Ho CKY; Raghwani J; Koekkoek S; Liang RH; Van der Meer JTM; Van Der Valk M; De Jong M; Pybus OG; Schinkel J; Molenkamp R J Virol; 2017 Mar; 91(6):. PubMed ID: 28077634 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus infection and polysubstance use among young adult people who inject drugs in a rural county of New Mexico. Wagner K; Zhong Y; Teshale E; White K; Winstanley EL; Hettema J; Thornton K; Bisztray B; Fiuty P; Page K Drug Alcohol Depend; 2021 Mar; 220():108527. PubMed ID: 33465605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]